FTCD

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA020073

Antibody CAB016409

Tissue

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Most of the malignant cells were either negative or showed weak cytoplasmic positivity. Occasional malignant cases displayed moderate cytoplasmic immunoreactivity e.g. endometrial, urothelial and liver cancers.A majority of malignant tissues were negative or exhibited weak cytoplasmic immunoreactivity. Moderate to strong positivity was seen in malignant melanomas and in few cases of malignant gliomas and adenocarcinomas.

Literature conformity

Partly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected